BIOLIFE SOLUTIONS INC cotiza a 38.61 USD y tiene una capitalización bursátil de $1.9B. En los últimos 12 meses ha facturado $103M con un margen de flujo de caja libre del 11.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biol…
| Periodo | 2026-11 |
|---|---|
| Real | — |
| Estimado | $0.07 |
| Sorpresa | — |
| Métrica | BLFS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 64.6% | 57.0% | +7.5% |
| Operating Margin | -17.3% | -38.6% | +21.4% |
| Net Margin | -4.8% | -33.6% | +28.8% |
| FCF Margin | 11.1% | -13.9% | +24.9% |
| ROE | -1.2% | -40.4% | +39.2% |
| ROA | -1.1% | -32.0% | +30.9% |
| Current Ratio | 5.94 | 2.84 | +3.10 |
| Debt / Equity | 0.01 | 0.28 | -0.27 |